FindTrial
Sign In

Clinical characteristics and disease progression in early-stage COVID-19 patients in South Korea

Clinical characteristics and disease progression in early-stage COVID-19 patients in South Korea

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005226
Enrollment
293
Registered
2020-07-13
Start date
2020-03-23
Completion date
Unknown
Last updated
2020-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Health System, Gangnam Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All consecutive patients with confirmed COVID-19 admitted to the Armed Forces Daegu Hospital, Daegu, South Korea, from March 5, 2020, to March 18, 2020, were enrolled in this study.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Whether symptoms aggravated (including radiological and/or clinical findings)—

Secondary

MeasureTime frame
Progression-free survival—

Countries

Korea, Republic of

Contacts

Public ContactMin Hyuk Choi

Yonsei University Health System, Gangnam Severance Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026